As veterinary surgeons, we are increasingly aware of the financial pressures facing our clients. Conversations about costs are now a routine part of clinical practice, taking up not an insignificant part of the consultation. 

If you’ve taken your pet to the vet recently, or your social media feed features more pet related posts, you have probably heard of the CMA’s investigation into the veterinary profession. The UK Competition and Markets Authority (CMA) has announced significant reforms to the veterinary sector, with a strong emphasis on pricing transparency. The intention is to improve client understanding, strengthen competition and ultimately address concerns about rising costs. 

From within the profession, the question is more nuanced: will greater transparency meaningfully reduce the cost of veterinary care, or simply change how those costs are communicated? 

Why has pricing transparency become a focus? 

Veterinary fees, not unlike any other fee, have risen considerably over the past decade. This reflects multiple factors familiar to those working in clinical practice, including: 

  • Increased availability and use of advanced diagnostics e.g. CT, more detailed in-house laboratory testing. 
  • Higher standards of patient care, including detailed anaesthetic and analgesic plans. 
  • Rising standing costs, particularly with ongoing recruitment challenges. 
  • Investment in facilities, equipment and regulatory compliance. 

From a clinical perspective, these developments represent progress. We are able to diagnose earlier, treat more effectively, and improve patient welfare. However, they inevitably increase the cost of care. 

The CMA have identified that, alongside these legitimate drivers, there are concerns about how clearly pricing is communicated to clients, and whether limited transparency reduces effective competition. 

What has the CMA decided? 

The CMA’s measures focus on making pricing more visible and understandable to clients, rather than directly controlling how much things cost. Key decisions include: 

  • Clear, accessible pricing information for common services. 
  • Provision of written estimates for higher-cost procedures. 
  • Itemised billing to improve understanding of charges. 
  • Greater transparency around prescription costs and options. 
  • A cap on prescription-writing fees. 
  • Clear disclosure of practice ownership. 

These changes are intended to reduce uncertainty and allow clients to make more informed decisions about their pet’s care. 

The potential benefits from a clinical perspective  

There are aspects of pricing transparency that align well with good veterinary practice. 

Improved client understanding and consent 

Informed consent is a cornerstone of veterinary ethics. Clear estimates and itemised costs can support more meaningful discussions, ensuring that clients understand both the clinical and financial implications of treatment. 

Strengthening trust 

A lack of clarity around pricing can erode trust, even when clinical care is appropriate. Transparency may help reduce perceptions of hidden costs or unexpected charges. 

Supporting shared decision-making 

When clients better understand costs, they may feel more able to engage in discussions about diagnostic and treatment options, including the risks and benefits of different approaches. 

Medication cost awareness 

Many clients remain unaware that prescriptions can be dispensed elsewhere. Increased transparency here may allow owners to make cost effective choices without compromising care. 

The limitations of transparency in reducing costs 

Despite these advantages, there are several reasons why transparency alone is unlikely to significantly reduce veterinary fees. 

“Veterinary medicine” is not a standardised product 

Unlike many consumer services, veterinary care is highly individualised. A consultation may lead to vastly different diagnostic and treatment pathways depending on clinical findings. This variability makes it difficult to present pricing in a way that is both accurate and meaningful. Even with estimates, costs can change as new information emerges, or the patients’ health status changes. 

Clinical decision making under time pressure 

In emergency cases, decisions are made rapidly, often with limited opportunity for comparison between practices. In these situations, animal welfare is paramount, therefore less emphasis is placed on cost transparency. 

Emotional factors 

Owners are frequently making decisions under emotional stress. In many cases, the priority is achieving the best possible outcome for the animal, rather than minimising cost. This reduces the extent to which price competition operates in clinical practice. 

Geographic and structural constraints 

In some areas, particularly rural locations, there may be limited choice of practices. Additionally, the growth of corporate ownership has changed the competitive landscape, which may influence how pricing behaves across the sector. 

Practical challenges for veterinary practices 

From a practitioner’s perspective, implementing pricing transparency is not without difficulty.  

Communicating complex pricing clearly 

Simplifying pricing without being misleading is challenging. For example, a “routine” procedure may vary significantly in complexity depending on the patient, and presenting a single price risks either underestimating or overestimating true costs. 

Time pressures in consultations 

Discussing detailed estimates, alternative options, and cost breakdowns requires time. In already busy clinical settings, this may add to workload and potentially impact consultation flow. 

Administrative and compliance burden 

Producing and maintaining accurate pricing information, ensuring consistency, and meeting regulatory requirements will require additional administrative resources. 

Risk of misinterpretation 

Without appropriate context, published prices may be misunderstood. Clients may compare costs between practices without recognising differences in facilities, staffing, or standards of care. 

So, will prices actually fall? 

From within the profession, it is unlikely that pricing transparency alone will lead to a substantial reduction in veterinary fees. The underlying drivers of cost, including advances in medical care, staffing and infrastructure, will remain unchanged. Veterinary medicine continues to evolve towards a higher standard of care, which inevitably carries a greater expense. 

However, transparency may have more subtle effects: 

  • Reducing variation in pricing between practices. 
  • Increasing client awareness of lower cost options, particularly for medications. 
  • Encouraging practices to reflect on how they present and justify their fees. 

In this sense, transparency may influence the distribution of costs rather than the overall level. 

The broader context 

It is important to recognise that pricing transparency is only one component of the CMA’s wider investigation, other areas under consideration, such as regulation of corporate ownership, may have a more significant long term impact on the structure of the veterinary market. 

From a professional perspective, there is also an ongoing responsibility to balance: 

  • Clinical excellence and patient welfare. 
  • Financial sustainability of practices. 
  • Accessibility of care for clients. 

These are complex and sometimes competing prioritise, and no single regulatory change is likely to resolve them entirely. 

A balanced perspective 

As veterinary surgeons, we recognise the importance of transparency and clear communication with clients. These are already central to good clinical practice and professional standards. The CMA’s proposals may help formalise and standardise these expectations, which could benefit both clients and the profession. However, it is important to be realistic about what transparency can achieve. It is unlikely to make veterinary care inexpensive, nor should it undermine the value of high-quality clinical care. Instead, its greatest contribution may be in improving understanding, supporting informed decision-making and strengthening trust between vets and pet owners. 

Conclusion 

Pricing transparency is a positive step towards greater openness in the veterinary profession. From a clinical perspective, it aligns with principles of informed consent, ethical practice and client communication. However, it is not a simple solution to rising costs. Veterinary care is inherently complex, individualised and resource-intensive. These factors will continue to shape pricing, regardless of how transparently it is presented. 

For clients, the likely outcome is not dramatically lower bills, but clearer expectations and greater confidence in the decisions they make for their pets. 

For the profession, the challenge will be to implement these changes in a way that maintains clinical standards, supports sustainable practice and preserves the trust at the heart of the veterinary-client relationship. 

See also: 

Final CMA Report into veterinary pricing – what it means for you and your vet practice 

Veterinary services for household pets – CMA